Page last updated: 2024-08-23

idarubicin and Myoclonic Jerk

idarubicin has been researched along with Myoclonic Jerk in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, AM; Mascarenhas, J; Rhee, JY; Tallman, MS; Tremblay, D	1

Reviews

1 review(s) available for idarubicin and Myoclonic Jerk

Article	Year
Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review. Blood advances, 2019, 06-25, Volume: 3, Issue:12 Topics: Aged; Antineoplastic Agents; Arsenic Poisoning; Arsenic Trioxide; Drug Therapy, Combination; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Myoclonus; Remission Induction; Steroids; Topoisomerase II Inhibitors; Treatment Outcome; Tretinoin; Withholding Treatment	2019

Article

Year

Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review.

Blood advances, 2019, 06-25, Volume: 3, Issue:12

Topics: Aged; Antineoplastic Agents; Arsenic Poisoning; Arsenic Trioxide; Drug Therapy, Combination; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Myoclonus; Remission Induction; Steroids; Topoisomerase II Inhibitors; Treatment Outcome; Tretinoin; Withholding Treatment

2019